Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Peter Douglas Lockhard Insider Profile
4 Followers
Peter Douglas Lockhard, Director at Biosyent, holds 860.73K shares in Biosyent (Ticker: TSE:RX). Most recently, Peter Douglas Lockhard Sold C$632 shares of Biosyent on May 23, 2024 for an estimated value of 5.67K.
Profitable Transactions
8 out of 12 Profitable Transactions
Average Return
+30.50%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Peter Douglas Lockhard's holdings
Insider Roles
Director
Roles that Peter Douglas Lockhard holds in companies
Most Profitable Insider Trade
The most profitable trade made by Peter Douglas Lockhard
Peter Douglas Lockhard's Trading History
List of latest transactions for each holding click on a transaction to see Peter Douglas Lockhard's performance on stock
You May Also Like
Peter Douglas Lockhard insider profile FAQ
What is the percentage of profitable transactions made by Peter Douglas Lockhard?
The percentage of profitable transactions made by Peter Douglas Lockhard is 67%.
What is the average return per transaction made by Peter Douglas Lockhard?
The average return per transaction made by Peter Douglas Lockhard is 30.50%.
What stocks does Peter Douglas Lockhard hold?
Peter Douglas Lockhard holds: TSE:RX stocks.
What was Peter Douglas Lockhard’s latest transaction?
Peter Douglas Lockhard latest transaction was an Informative Sell of C$5.67K.
What was Peter Douglas Lockhard's most profitable transaction?
Peter Douglas Lockhard’s most profitable transaction was an Informative Buy of TSE:RX stock on January 29, 2014. The return on the trade was 203.30%.
What is Peter Douglas Lockhard's role in Biosyent?
Peter Douglas Lockhard's role in Biosyent is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.